• レポートコード:GIR-22E8525 • 出版社/出版日:GlobalInfoResearch / 2022年5月 • レポート形態:英文、PDF、112ページ • 納品方法:Eメール(2~3営業日) • 産業分類:医療機器 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
ウイルス検査市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のウイルス検査の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。 ウイルス検査市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・直接蛍光抗体(DFA)テスト、免疫クロマトグラフィーアッセイ、RT-PCRベースのテスト、凝集アッセイ、フロースルーアッセイ、固相アッセイ 用途別セグメントは次のように区分されます。 ・研究室、病院、在宅医療、学術研究所 世界のウイルス検査市場の主要な市場プレーヤーは以下のとおりです。 ・Roche、Agilent Technologies、Thermo Fisher Scientific、QIAGEN International、Lonza、Wuxi Pharmatech (Cayman)、Merck、Eurofins Scientific、General Electric、Danaher、Bio-Rad Laboratories、BD、Biospherix、Novogene Corporation、Sartorius 地域別セグメントは次の地域・国をカバーします。 ・北米(米国、カナダ、メキシコ) ・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア) ・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア) ・南アメリカ(ブラジル、アルゼンチン、コロンビア) ・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ) 本調査レポートの内容は計15章あります。 ・第1章では、ウイルス検査製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なウイルス検査メーカーの企業概要、2019年~2022年までのウイルス検査の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なウイルス検査メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年~2028年までの地域別ウイルス検査の販売量、売上、成長性を示しています。 ・第5、6章では、2017年~2028年までのウイルス検査の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのウイルス検査市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびウイルス検査の産業チェーンを掲載しています。 ・第13、14、15章では、ウイルス検査の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報(企業概要、製品概要、販売量、価格、売上):Roche、Agilent Technologies、Thermo Fisher Scientific、QIAGEN International、Lonza、Wuxi Pharmatech (Cayman)、Merck、Eurofins Scientific、General Electric、Danaher、Bio-Rad Laboratories、BD、Biospherix、Novogene Corporation、Sartorius ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年:直接蛍光抗体(DFA)テスト、免疫クロマトグラフィーアッセイ、RT-PCRベースのテスト、凝集アッセイ、フロースルーアッセイ、固相アッセイ ・用途別分析2017年-2028年:研究室、病院、在宅医療、学術研究所 ・ウイルス検査の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ ・ウイルス検査のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア ・ウイルス検査のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア ・ウイルス検査の南米市場規模2017年-2028年:ブラジル、アルゼンチン ・ウイルス検査の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Viral Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Viral Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Laboratory accounting for % of the Viral Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Direct Fluorescent Antibody (DFA) Test segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Viral Testing include Roche, Agilent Technologies, Thermo Fisher Scientific, QIAGEN International, and Lonza, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Viral Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Direct Fluorescent Antibody (DFA) Test
Immunochromatographic Assay
RT-PCR-Based Test
Agglutination Assay
Flow-Through Assay
Solid-Phase Assay
Market segment by Application can be divided into
Laboratory
Hospital
Home Care
Academic Institute
The key market players for global Viral Testing market are listed below:
Roche
Agilent Technologies
Thermo Fisher Scientific
QIAGEN International
Lonza
Wuxi Pharmatech (Cayman)
Merck
Eurofins Scientific
General Electric
Danaher
Bio-Rad Laboratories
BD
Biospherix
Novogene Corporation
Sartorius
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Viral Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Viral Testing, with price, sales, revenue and global market share of Viral Testing from 2019 to 2022.
Chapter 3, the Viral Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viral Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Viral Testing market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Testing.
Chapter 13, 14, and 15, to describe Viral Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Viral Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Viral Testing Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Direct Fluorescent Antibody (DFA) Test
1.2.3 Immunochromatographic Assay
1.2.4 RT-PCR-Based Test
1.2.5 Agglutination Assay
1.2.6 Flow-Through Assay
1.2.7 Solid-Phase Assay
1.3 Market Analysis by Application
1.3.1 Overview: Global Viral Testing Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Home Care
1.3.5 Academic Institute
1.4 Global Viral Testing Market Size & Forecast
1.4.1 Global Viral Testing Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Viral Testing Sales in Volume (2017-2028)
1.4.3 Global Viral Testing Price (2017-2028)
1.5 Global Viral Testing Production Capacity Analysis
1.5.1 Global Viral Testing Total Production Capacity (2017-2028)
1.5.2 Global Viral Testing Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Viral Testing Market Drivers
1.6.2 Viral Testing Market Restraints
1.6.3 Viral Testing Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Viral Testing Product and Services
2.1.4 Roche Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Viral Testing Product and Services
2.2.4 Agilent Technologies Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Viral Testing Product and Services
2.3.4 Thermo Fisher Scientific Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 QIAGEN International
2.4.1 QIAGEN International Details
2.4.2 QIAGEN International Major Business
2.4.3 QIAGEN International Viral Testing Product and Services
2.4.4 QIAGEN International Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Viral Testing Product and Services
2.5.4 Lonza Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Wuxi Pharmatech (Cayman)
2.6.1 Wuxi Pharmatech (Cayman) Details
2.6.2 Wuxi Pharmatech (Cayman) Major Business
2.6.3 Wuxi Pharmatech (Cayman) Viral Testing Product and Services
2.6.4 Wuxi Pharmatech (Cayman) Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Viral Testing Product and Services
2.7.4 Merck Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eurofins Scientific
2.8.1 Eurofins Scientific Details
2.8.2 Eurofins Scientific Major Business
2.8.3 Eurofins Scientific Viral Testing Product and Services
2.8.4 Eurofins Scientific Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 General Electric
2.9.1 General Electric Details
2.9.2 General Electric Major Business
2.9.3 General Electric Viral Testing Product and Services
2.9.4 General Electric Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Danaher
2.10.1 Danaher Details
2.10.2 Danaher Major Business
2.10.3 Danaher Viral Testing Product and Services
2.10.4 Danaher Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Viral Testing Product and Services
2.11.4 Bio-Rad Laboratories Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BD
2.12.1 BD Details
2.12.2 BD Major Business
2.12.3 BD Viral Testing Product and Services
2.12.4 BD Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Biospherix
2.13.1 Biospherix Details
2.13.2 Biospherix Major Business
2.13.3 Biospherix Viral Testing Product and Services
2.13.4 Biospherix Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Novogene Corporation
2.14.1 Novogene Corporation Details
2.14.2 Novogene Corporation Major Business
2.14.3 Novogene Corporation Viral Testing Product and Services
2.14.4 Novogene Corporation Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Sartorius
2.15.1 Sartorius Details
2.15.2 Sartorius Major Business
2.15.3 Sartorius Viral Testing Product and Services
2.15.4 Sartorius Viral Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Viral Testing Breakdown Data by Manufacturer
3.1 Global Viral Testing Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Viral Testing Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Viral Testing
3.4 Market Concentration Rate
3.4.1 Top 3 Viral Testing Manufacturer Market Share in 2021
3.4.2 Top 6 Viral Testing Manufacturer Market Share in 2021
3.5 Global Viral Testing Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Viral Testing Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Viral Testing Market Size by Region
4.1.1 Global Viral Testing Sales in Volume by Region (2017-2028)
4.1.2 Global Viral Testing Revenue by Region (2017-2028)
4.2 North America Viral Testing Revenue (2017-2028)
4.3 Europe Viral Testing Revenue (2017-2028)
4.4 Asia-Pacific Viral Testing Revenue (2017-2028)
4.5 South America Viral Testing Revenue (2017-2028)
4.6 Middle East and Africa Viral Testing Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Viral Testing Sales in Volume by Type (2017-2028)
5.2 Global Viral Testing Revenue by Type (2017-2028)
5.3 Global Viral Testing Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Viral Testing Sales in Volume by Application (2017-2028)
6.2 Global Viral Testing Revenue by Application (2017-2028)
6.3 Global Viral Testing Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Viral Testing Sales by Type (2017-2028)
7.2 North America Viral Testing Sales by Application (2017-2028)
7.3 North America Viral Testing Market Size by Country
7.3.1 North America Viral Testing Sales in Volume by Country (2017-2028)
7.3.2 North America Viral Testing Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Viral Testing Sales by Type (2017-2028)
8.2 Europe Viral Testing Sales by Application (2017-2028)
8.3 Europe Viral Testing Market Size by Country
8.3.1 Europe Viral Testing Sales in Volume by Country (2017-2028)
8.3.2 Europe Viral Testing Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Viral Testing Sales by Type (2017-2028)
9.2 Asia-Pacific Viral Testing Sales by Application (2017-2028)
9.3 Asia-Pacific Viral Testing Market Size by Region
9.3.1 Asia-Pacific Viral Testing Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Viral Testing Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Viral Testing Sales by Type (2017-2028)
10.2 South America Viral Testing Sales by Application (2017-2028)
10.3 South America Viral Testing Market Size by Country
10.3.1 South America Viral Testing Sales in Volume by Country (2017-2028)
10.3.2 South America Viral Testing Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Viral Testing Sales by Type (2017-2028)
11.2 Middle East & Africa Viral Testing Sales by Application (2017-2028)
11.3 Middle East & Africa Viral Testing Market Size by Country
11.3.1 Middle East & Africa Viral Testing Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Viral Testing Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Viral Testing and Key Manufacturers
12.2 Manufacturing Costs Percentage of Viral Testing
12.3 Viral Testing Production Process
12.4 Viral Testing Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Viral Testing Typical Distributors
13.3 Viral Testing Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer